Plasma IgG aggregates as biomarkers for multiple sclerosis

We recently reported that multiple sclerosis (MS) plasma contains IgG aggregates and induces complement-dependent neuronal cytotoxicity (Zhou et al., 2023). Using ELISA, we report herein that plasma IgG levels in the aggregates can be used as biomarkers for MS. We enriched the IgG aggregates from sa...

Full description

Saved in:
Bibliographic Details
Published in:Clinical immunology (Orlando, Fla.) Fla.), 2023-11, Vol.256, p.109801-109801, Article 109801
Main Authors: Zhou, Wenbo, Graner, Michael, Beseler, Cheryl, Domashevich, Timothy, Selva, Sean, Webster, Gill, Ledreux, Aurelie, Zizzo, Zoe, Lundt, Max, Alvarez, Enrique, Yu, Xiaoli
Format: Article
Language:English
Subjects:
Antibody
Biomarker
Cytotoxicity
Diagnosis
IgG
IgG aggregates
IgG1
Immunoglobulin
Multiple sclerosis
Plasma
Progressive MS
SPMS
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We recently reported that multiple sclerosis (MS) plasma contains IgG aggregates and induces complement-dependent neuronal cytotoxicity (Zhou et al., 2023). Using ELISA, we report herein that plasma IgG levels in the aggregates can be used as biomarkers for MS. We enriched the IgG aggregates from samples of two cohorts (190 MS and 160 controls) by collecting flow-through after plasma binding to Protein A followed by detection of IgG subclass. We show that there are significantly higher levels of IgG1, IgG3, and total IgG antibodies in MS IgG aggregates, with an AUC >90%; higher levels of IgG1 distinguish secondary progressive MS from relapsing-remitting MS (AUC = 91%). Significantly, we provided the biological rationale for MS plasma IgG biomarkers by demonstrating the strong correlation between IgG antibodies and IgG aggregate-induced neuronal cytotoxicity. These non-invasive, simple IgG-based blood ELISA assays can be adapted into clinical practice for diagnosing MS and SPMS and monitoring treatment responses. •Enriched the IgG aggregates by collecting flow-through after plasma binding to Protein A (A-FT).•Significantly higher levels of IgG1, IgG3, and total IgG antibodies in MS plasma A-FT.•Higher plasma IgG1 can distinguish secondary progressive MS (SPMS) from relapsing-remitting MS (RRMS).•Strong correlation between IgG antibodies and IgG-induced neuronal cytotoxicity.•Provided evidence for a noninvasive blood-based IgG biomarker for MS.
ISSN:1521-6616
1521-7035
DOI:10.1016/j.clim.2023.109801